Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MH004 in Healthy Volunteers and Atopic Dermatitis
NCT07182864Phase 2Completed
- Sponsor
- Minghui Pharmaceutical, Inc.
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of INN-04-01 in atopic dermatitis (AD), sponsored by Minghui Pharmaceutical, Inc.. Started Jan 2022; status: completed.
02
Drugs
INN-04-01
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07182864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07182864.